title: [Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry].
abstract: OBJECTIVE
  Elevated heart rate (70 beats per minute-bpm or more) is a predictor of impaired prognosis in patients with ischemic heart failure. The Austrian Working Group on Heart Failure has established a registry in May 2006 for all patients referred to dedicated heart failure clinics with a planned follow-up after 12 ± 3 months. Here we report an analysis of the prognostic impact of elevated heart rate at referral in a well-defined cohort of heart failure patients.
  
  
  METHODS
  Between May 2006 and October 2009 1904 patients have been documented in the Austrian Heart Failure Registry. One thousand threehundred and sixty three patients (72%) had sinus rhythm at referral. Kaplan-Meier and Cox proportional hazards regression analyses were used to compare overall and cardiovascular mortality between high (70 bpm or more) and low heart-rate groups. Patients who were lost-to-follow-up (n = 166) were censored at the time of last contact.
  
  
  RESULTS
  At baseline in 793 patients (58%) heart rate has been elevated (70 bpm or more) while in 562 patients it has been below 70 bpm, in 8 patients no baseline heart rate has been recorded. Groups were equally balanced regarding age, gender and cardiovascular risk factors with the exception of smokers (more active smokers in the high heart-rate group: 23 vs 14%; p = 0.001) and valvular cause of heart failure (more frequent in the high heart-rate group: 3% vs 1%; p = 0.012). Patients in the high heart-rate group had significantly higher median NT-pro-BNP (1470 pg/ml, IQR 499-4188 pg/ml) compared to patients in the low heart-rate group (784 pg/ml, IQR 314-2162 pg/ml; p < 0.001). NYHA functional classes III and IV have been more frequent in the high heart-rate group than in the low heart-rate group (32% and 22%, respectively; p < 0.001) while reduced left ventricular ejection fraction (39% or less) has been more frequent in the high heart-rate group than in the low heart-rate group (71% and 61%, respectively; p < 0.001). In the high heart-rate group treatment with beta-blockers has been less frequent than in the low heart rate group (76% and 86%, respectively; p < 0.01) while dosage of beta-blocker therapy has been comparable in both groups. Of the 75 patients who died within 3.5 years 38 deaths had a cardiovascular cause. Cox proportional hazards analysis revealed that high NYHA functional class (III and IV) and elevated heart rate (70 bpm or more) were the best predictors of overall mortality while cardiovascular mortality could best be predicted by NYHA functional classes III and IV.
  
  
  CONCLUSIONS
  Higher NYHA-functional classes and elevated heart rate are predictors of adverse outcome in chronic heart failure patients.
authors: Universitätsklinik für Innere Medizin, Abteilung für Kardiologie, Medizinische Universität Graz, Graz, Austria. friedrich.fruhwald@medunigraz.at
authors: Friedrich M
authors: FM
authors: Fruhwald
authors: Hanno
authors: H
authors: Ulmer
authors: Richard
authors: R
authors: Pacher
authors: Gerhard
authors: G
authors: Pölzl
authors: Claudia
authors: C
authors: Dornaus
authors: Manfred
authors: M
authors: Wieser
authors: Christian
authors: C
authors: Ebner
authors: Susanne
authors: S
authors: Reiter
authors: Lalit
authors: L
authors: Kaltenbach
authors: Johann
authors: J
authors: Altenberger
references: J Am Coll Cardiol. 1999 Mar;33(3):734-42
references: 10080475
references: N Engl J Med. 2003 Apr 3;348(14):1309-21
references: 12668699
references: Am Heart J. 2007 Jun;153(6):1021-8
references: 17540205
references: Eur Heart J. 2003 Mar;24(5):464-74
references: 12633547
references: Eur Heart J. 2005 Aug;26(16):1653-9
references: 15827061
references: N Engl J Med. 2004 May 20;350(21):2140-50
references: 15152059
references: Eur Heart J. 2009 Oct;30(20):2450-60
references: 19723694
references: N Engl J Med. 2005 Apr 14;352(15):1539-49
references: 15753115
references: Lancet. 2008 Sep 6;372(9641):817-21
references: 18757091
references: Eur J Heart Fail. 2008 Oct;10(10):933-89
references: 18826876
references: N Engl J Med. 2009 Oct 1;361(14):1329-38
references: 19723701
references: N Engl J Med. 1999 Sep 2;341(10):709-17
references: 10471456
references: Eur Heart J. 2003 Mar;24(5):442-63
references: 12633546
references: Lancet. 2010 Sep 11;376(9744):875-85
references: 20801500
references: Lancet. 2010 Sep 11;376(9744):886-94
references: 20801495
references: Eur J Heart Fail. 2010 Oct;12(10):1076-84
references: 20805094
references: Eur J Heart Fail. 2001 Jun;3(3):315-22
references: 11378002